COX-2 Overexpression in Colorectal Neoplasias
Author Information
Author(s): Kawasaki Takako, Nosho Katsuhiko, Ohnishi Mutsuko, Suemoto Yuko, Glickman Jonathan N, Chan Andrew T, Kirkner Gregory J, Mino-Kenudson Mari, Fuchs Charles S, Ogino Shuji
Primary Institution: Dana-Farber Cancer Institute
Hypothesis
COX-2 may play a less important role in the serrated pathway of colorectal cancer.
Conclusion
COX-2 overexpression is infrequent in hyperplastic polyps and serrated polyps compared to non-serrated adenomas.
Supporting Evidence
- COX-2 overexpression was found in 28% of non-serrated adenomas.
- Only 4.2% of hyperplastic polyps showed strong COX-2 overexpression.
- COX-2 overexpression was not correlated with tumor location.
Takeaway
This study found that a protein called COX-2 is not very common in certain types of colorectal polyps, but it is more common in other types as they become more serious.
Methodology
Immunohistochemistry was used to assess COX-2 expression in various colorectal neoplasias.
Potential Biases
Potential bias in the selection of tissue samples and interpretation of results.
Limitations
The study may not account for all potential confounding factors related to COX-2 expression.
Participant Demographics
Mean age of participants was 60.8 years, with a mix of men and women from two large cohort studies.
Statistical Information
P-Value
p < 0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website